6 Results

People

  1. Kris
    Kris
  2. Scher
    Scher
  3. Armstrong
    Armstrong
  4. Fass
    Fass
  5. Fuks
    Fuks
  6. Harrison
    Harrison
  7. Leibel
    Leibel
  8. Miller
    Miller
  9. Sirotnak
    Sirotnak
  10. Baselga
    Baselga

Groups

  1. Department of Medicine (6)
  2. Genitourinary Oncology Service (6)
  3. Solid Tumor Oncology Division (6)
  4. Thoracic Oncology (6)
  5. GSK Faculty (3)
  6. Sloan Kettering Institute Faculty (3)
  7. Molecular Pharmacology and Chemistry Program Faculty (2)
  8. Cancer Biology and Genetics Program Faculty (1)
  9. Radiation Oncology, Department of (1)
  10. Survivorship Research (1)
  1. "priority journal"
  2. "Howard Scher"
  3. "Mark Kris"
Formats
  1. Journal Article (5)
  2. Conference Paper (1)
Groups
  1. Department of Medicine (6)
  2. Genitourinary Oncology Service (6)
  3. Solid Tumor Oncology Division (6)
  4. Thoracic Oncology (6)
  5. GSK Faculty (3)
  6. Sloan Kettering Institute Faculty (3)

More Groups

People
  1. Howard Scher (6)
  2. Mark Kris (6)
  3. Daniel Fass (3)
  4. John Armstrong (3)
  5. Francis Sirotnak (2)
  6. Louis Harrison (2)

More People

Years
  1. 2000 (2)
  2. 1993 (1)
  3. 1992 (1)
  4. 1991 (2)
Publications
  1. Clinical Cancer Research (2)
  2. International Journal of Radiation Oncology, Biology, Physics (2)
  3. Investigational New Drugs (1)
  4. Radiology (1)
Publishers
  1. American Association for Cancer Research (2)
  2. Elsevier Inc. (2)
  3. Radiological Society of North America, Inc. (1)
  4. Springer (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase
    Journal Article

    Sirotnak, F. M.; Zakowski, M. F.; Miller, V. A.; Scher, H. I.; Kris, M. G.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Co-administration of probenecid, an inhibitor of a cMOAT/MRP-like plasma membrane ATPase, greatly enhanced the efficacy of a new 10-deazaaminopterin against human solid tumors in vivo
    Journal Article

    Sirotnak, F. M.; Wendel, H. G.; Bornmann, W. G. B.; Tong, W. P.; Miller, V. A.; Scher, H. I.; Kris, M. G.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Phase II trial of gallium nitrate in previously treated patients with small cell lung cancer
    Journal Article

    Baselga, J.; Kris, M. G.; Scher, H. I.; Phillips, M.; Heelan, R. T.
    Investigational New Drugs (1993)

    Fulltext@MSK | Save
  • A reappraisal of the role of prophylactic cranial irradiation in limited small cell lung cancer
    Journal Article

    Rosenstein, M.; Armstrong, J.; Kris, M.; Shank, B.; Scher, H.; Fass, D.; Harrison, L.; Fuks, Z.; Leibel, S.
    International Journal of Radiation Oncology, Biology, Physics (1992)

    Fulltext@MSK | Save
  • Limited small cell lung cancer: Prognostic significance of a complete response to the induction phase of chemotherapy followed by thoracic irradiation
    Journal Article

    Armstrong, J. G.; Rosenstein, M. M.; Scher, H. I.; Fass, D. E.; Zelefsky, M. J.; Kris, M. G.
    Radiology (1991)

    Fulltext@MSK | Save
  • Twice daily thoracic irradiation for limited small cell lung cancer
    Conference Paper

    Armstrong, J. G.; Rosenstein, M. M.; Kris, M. G.; Shank, B. M.; Scher, H. I.; Fass, D. E.; Harrison, L. B.; Leibel, S. A.; Fuks, Z. Y.
    Elsevier Inc. (1991)

    Fulltext@MSK | Save